Tailoring the targeted treatment of chronic lymphocytic leukemia
Bidragets beskrivning
The CLL-CLUE project will identify novel biomarkers and implement AI-based clinical decision support systems to guide personalized treatment decisions in CLL. We expect that this will lead to significantly increased treatment efficacy, individualization of therapy and reduced drug use and side effects. In addition, reduced consumption of drugs and cost-effective outcomes will lower financial stress that the health care providers and patients experience.
Visa merStartår
2021
Slutår
2025
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Kansainvälinen yhteisrahoitteinen ohjelma
Övriga uppgifter
Finansieringsbeslutets nummer
344698
Vetenskapsområden
Data- och informationsvetenskap
Forskningsområden
Laskennallinen tiede
Identifierade teman
cancer